ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC30964-5mg |
|
887258-94-8 |
Vabicaserin hydrochloride (SCA 136)
|
0 | C15H21ClN2 | |
GC30964-10mM(1mLinDMSO) |
|
887258-94-8 |
Vabicaserin hydrochloride (SCA 136)
|
0 | C15H21ClN2 | |
GC30963-50mg |
|
87940-60-1 |
Eprobemide (LIS 630)
|
0 | C14H19ClN2O2 | |
GC30963-25mg |
|
87940-60-1 |
Eprobemide (LIS 630)
|
0 | C14H19ClN2O2 | |
GC30963-10mg |
|
87940-60-1 |
Eprobemide (LIS 630)
|
0 | C14H19ClN2O2 | |
GC30963-5mg |
|
87940-60-1 |
Eprobemide (LIS 630)
|
0 | C14H19ClN2O2 | |
GC30963-10mM(1mLinDMSO) |
|
87940-60-1 |
Eprobemide (LIS 630)
|
0 | C14H19ClN2O2 | |
GC30962-1g |
|
142-88-1 |
Piperazine adipate
|
0 | C10H20N2O4 | |
GC30962-200mg |
|
142-88-1 |
Piperazine adipate
|
0 | C10H20N2O4 | |
GC30962-10mM(1mLinWater) |
|
142-88-1 |
Piperazine adipate
|
0 | C10H20N2O4 | |
GC30961-100mg |
|
1138245-21-2 |
Mirogabalin besylate (DS 5565 besylate)
|
0 | C18H25NO5S | |
GC30961-50mg |
|
1138245-21-2 |
Mirogabalin besylate (DS 5565 besylate)
|
0 | C18H25NO5S | |
GC30961-10mg |
|
1138245-21-2 |
Mirogabalin besylate (DS 5565 besylate)
|
0 | C18H25NO5S | |
GC30961-5mg |
|
1138245-21-2 |
Mirogabalin besylate (DS 5565 besylate)
|
0 | C18H25NO5S | |
GC30961-10mM(1mLinDMSO) |
|
1138245-21-2 |
Mirogabalin besylate (DS 5565 besylate)
|
0 | C18H25NO5S | |
GC30960-10mg |
|
21802-37-9 |
Caerulomycin A (Cerulomycin)
|
0 | C12H11N3O2 | |
GC30960-5mg |
|
21802-37-9 |
Caerulomycin A (Cerulomycin)
|
0 | C12H11N3O2 | |
GC30960-1mg |
|
21802-37-9 |
Caerulomycin A (Cerulomycin)
|
0 | C12H11N3O2 | |
GC30960-10mM(1mLinDMSO) |
|
21802-37-9 |
Caerulomycin A (Cerulomycin)
|
0 | C12H11N3O2 | |
GC30959-100mg |
|
94-15-5 |
Dimethocaine (Larocaine)
|
0 | C16H26N2O2 | |